The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Tetanic Toxoid Market Research Report 2025

Global Tetanic Toxoid Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1884102

No of Pages : 74

Ask Your Query

Synopsis

Tetanus toxoid is mainly used to prevent the occurrence of tetanus, but also can be used to treat tetanus, tetanus toxoid injected into the human body will produce antitoxin, effective prevention of tetanus.

The global Tetanic Toxoid market was valued at US$ 168 million in 2023 and is anticipated to reach US$ 418.2 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.

North American market for Tetanic Toxoid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tetanic Toxoid is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Tetanic Toxoid in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Tetanic Toxoid include BB-NCIPD, Bio Farma, Biological E, Sanofi, GlaxoSmithKline, Accord Healthcare Inc and Shanha Biotechniques, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Tetanic Toxoid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tetanic Toxoid.

Report Scope

The Tetanic Toxoid market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Tetanic Toxoid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Tetanic Toxoid companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • BB-NCIPD
  • Bio Farma
  • Biological E
  • Sanofi
  • GlaxoSmithKline
  • Accord Healthcare Inc
  • Shanha Biotechniques

Segment by Type

  • Tetanus Toxin Spasm
  • Hemolytic Toxin

Segment by Application

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tetanic Toxoid companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tetanic Toxoid Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tetanus Toxin Spasm
1.2.3 Hemolytic Toxin
1.3 Market by Application
1.3.1 Global Tetanic Toxoid Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tetanic Toxoid Market Perspective (2019-2030)
2.2 Tetanic Toxoid Growth Trends by Region
2.2.1 Global Tetanic Toxoid Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Tetanic Toxoid Historic Market Size by Region (2019-2024)
2.2.3 Tetanic Toxoid Forecasted Market Size by Region (2025-2030)
2.3 Tetanic Toxoid Market Dynamics
2.3.1 Tetanic Toxoid Industry Trends
2.3.2 Tetanic Toxoid Market Drivers
2.3.3 Tetanic Toxoid Market Challenges
2.3.4 Tetanic Toxoid Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tetanic Toxoid Players by Revenue
3.1.1 Global Top Tetanic Toxoid Players by Revenue (2019-2024)
3.1.2 Global Tetanic Toxoid Revenue Market Share by Players (2019-2024)
3.2 Global Tetanic Toxoid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tetanic Toxoid Revenue
3.4 Global Tetanic Toxoid Market Concentration Ratio
3.4.1 Global Tetanic Toxoid Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tetanic Toxoid Revenue in 2023
3.5 Tetanic Toxoid Key Players Head office and Area Served
3.6 Key Players Tetanic Toxoid Product Solution and Service
3.7 Date of Enter into Tetanic Toxoid Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tetanic Toxoid Breakdown Data by Type
4.1 Global Tetanic Toxoid Historic Market Size by Type (2019-2024)
4.2 Global Tetanic Toxoid Forecasted Market Size by Type (2025-2030)
5 Tetanic Toxoid Breakdown Data by Application
5.1 Global Tetanic Toxoid Historic Market Size by Application (2019-2024)
5.2 Global Tetanic Toxoid Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Tetanic Toxoid Market Size (2019-2030)
6.2 North America Tetanic Toxoid Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Tetanic Toxoid Market Size by Country (2019-2024)
6.4 North America Tetanic Toxoid Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Tetanic Toxoid Market Size (2019-2030)
7.2 Europe Tetanic Toxoid Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Tetanic Toxoid Market Size by Country (2019-2024)
7.4 Europe Tetanic Toxoid Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tetanic Toxoid Market Size (2019-2030)
8.2 Asia-Pacific Tetanic Toxoid Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Tetanic Toxoid Market Size by Region (2019-2024)
8.4 Asia-Pacific Tetanic Toxoid Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Tetanic Toxoid Market Size (2019-2030)
9.2 Latin America Tetanic Toxoid Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Tetanic Toxoid Market Size by Country (2019-2024)
9.4 Latin America Tetanic Toxoid Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tetanic Toxoid Market Size (2019-2030)
10.2 Middle East & Africa Tetanic Toxoid Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Tetanic Toxoid Market Size by Country (2019-2024)
10.4 Middle East & Africa Tetanic Toxoid Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BB-NCIPD
11.1.1 BB-NCIPD Company Detail
11.1.2 BB-NCIPD Business Overview
11.1.3 BB-NCIPD Tetanic Toxoid Introduction
11.1.4 BB-NCIPD Revenue in Tetanic Toxoid Business (2019-2024)
11.1.5 BB-NCIPD Recent Development
11.2 Bio Farma
11.2.1 Bio Farma Company Detail
11.2.2 Bio Farma Business Overview
11.2.3 Bio Farma Tetanic Toxoid Introduction
11.2.4 Bio Farma Revenue in Tetanic Toxoid Business (2019-2024)
11.2.5 Bio Farma Recent Development
11.3 Biological E
11.3.1 Biological E Company Detail
11.3.2 Biological E Business Overview
11.3.3 Biological E Tetanic Toxoid Introduction
11.3.4 Biological E Revenue in Tetanic Toxoid Business (2019-2024)
11.3.5 Biological E Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Tetanic Toxoid Introduction
11.4.4 Sanofi Revenue in Tetanic Toxoid Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Tetanic Toxoid Introduction
11.5.4 GlaxoSmithKline Revenue in Tetanic Toxoid Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Accord Healthcare Inc
11.6.1 Accord Healthcare Inc Company Detail
11.6.2 Accord Healthcare Inc Business Overview
11.6.3 Accord Healthcare Inc Tetanic Toxoid Introduction
11.6.4 Accord Healthcare Inc Revenue in Tetanic Toxoid Business (2019-2024)
11.6.5 Accord Healthcare Inc Recent Development
11.7 Shanha Biotechniques
11.7.1 Shanha Biotechniques Company Detail
11.7.2 Shanha Biotechniques Business Overview
11.7.3 Shanha Biotechniques Tetanic Toxoid Introduction
11.7.4 Shanha Biotechniques Revenue in Tetanic Toxoid Business (2019-2024)
11.7.5 Shanha Biotechniques Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Tetanic Toxoid Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tetanus Toxin Spasm
Table 3. Key Players of Hemolytic Toxin
Table 4. Global Tetanic Toxoid Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Tetanic Toxoid Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Tetanic Toxoid Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Tetanic Toxoid Market Share by Region (2019-2024)
Table 8. Global Tetanic Toxoid Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Tetanic Toxoid Market Share by Region (2025-2030)
Table 10. Tetanic Toxoid Market Trends
Table 11. Tetanic Toxoid Market Drivers
Table 12. Tetanic Toxoid Market Challenges
Table 13. Tetanic Toxoid Market Restraints
Table 14. Global Tetanic Toxoid Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Tetanic Toxoid Market Share by Players (2019-2024)
Table 16. Global Top Tetanic Toxoid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tetanic Toxoid as of 2023)
Table 17. Ranking of Global Top Tetanic Toxoid Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Tetanic Toxoid Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Tetanic Toxoid Product Solution and Service
Table 21. Date of Enter into Tetanic Toxoid Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Tetanic Toxoid Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Tetanic Toxoid Revenue Market Share by Type (2019-2024)
Table 25. Global Tetanic Toxoid Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Tetanic Toxoid Revenue Market Share by Type (2025-2030)
Table 27. Global Tetanic Toxoid Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Tetanic Toxoid Revenue Market Share by Application (2019-2024)
Table 29. Global Tetanic Toxoid Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Tetanic Toxoid Revenue Market Share by Application (2025-2030)
Table 31. North America Tetanic Toxoid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Tetanic Toxoid Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Tetanic Toxoid Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Tetanic Toxoid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Tetanic Toxoid Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Tetanic Toxoid Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Tetanic Toxoid Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Tetanic Toxoid Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Tetanic Toxoid Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Tetanic Toxoid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Tetanic Toxoid Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Tetanic Toxoid Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Tetanic Toxoid Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Tetanic Toxoid Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Tetanic Toxoid Market Size by Country (2025-2030) & (US$ Million)
Table 46. BB-NCIPD Company Detail
Table 47. BB-NCIPD Business Overview
Table 48. BB-NCIPD Tetanic Toxoid Product
Table 49. BB-NCIPD Revenue in Tetanic Toxoid Business (2019-2024) & (US$ Million)
Table 50. BB-NCIPD Recent Development
Table 51. Bio Farma Company Detail
Table 52. Bio Farma Business Overview
Table 53. Bio Farma Tetanic Toxoid Product
Table 54. Bio Farma Revenue in Tetanic Toxoid Business (2019-2024) & (US$ Million)
Table 55. Bio Farma Recent Development
Table 56. Biological E Company Detail
Table 57. Biological E Business Overview
Table 58. Biological E Tetanic Toxoid Product
Table 59. Biological E Revenue in Tetanic Toxoid Business (2019-2024) & (US$ Million)
Table 60. Biological E Recent Development
Table 61. Sanofi Company Detail
Table 62. Sanofi Business Overview
Table 63. Sanofi Tetanic Toxoid Product
Table 64. Sanofi Revenue in Tetanic Toxoid Business (2019-2024) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. GlaxoSmithKline Company Detail
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Tetanic Toxoid Product
Table 69. GlaxoSmithKline Revenue in Tetanic Toxoid Business (2019-2024) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Accord Healthcare Inc Company Detail
Table 72. Accord Healthcare Inc Business Overview
Table 73. Accord Healthcare Inc Tetanic Toxoid Product
Table 74. Accord Healthcare Inc Revenue in Tetanic Toxoid Business (2019-2024) & (US$ Million)
Table 75. Accord Healthcare Inc Recent Development
Table 76. Shanha Biotechniques Company Detail
Table 77. Shanha Biotechniques Business Overview
Table 78. Shanha Biotechniques Tetanic Toxoid Product
Table 79. Shanha Biotechniques Revenue in Tetanic Toxoid Business (2019-2024) & (US$ Million)
Table 80. Shanha Biotechniques Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tetanic Toxoid Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Tetanic Toxoid Market Share by Type: 2023 VS 2030
Figure 3. Tetanus Toxin Spasm Features
Figure 4. Hemolytic Toxin Features
Figure 5. Global Tetanic Toxoid Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Tetanic Toxoid Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Tetanic Toxoid Report Years Considered
Figure 11. Global Tetanic Toxoid Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Tetanic Toxoid Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Tetanic Toxoid Market Share by Region: 2023 VS 2030
Figure 14. Global Tetanic Toxoid Market Share by Players in 2023
Figure 15. Global Top Tetanic Toxoid Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tetanic Toxoid as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Tetanic Toxoid Revenue in 2023
Figure 17. North America Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Tetanic Toxoid Market Share by Country (2019-2030)
Figure 19. United States Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Tetanic Toxoid Market Share by Country (2019-2030)
Figure 23. Germany Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Tetanic Toxoid Market Share by Region (2019-2030)
Figure 31. China Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Tetanic Toxoid Market Share by Country (2019-2030)
Figure 39. Mexico Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Tetanic Toxoid Market Share by Country (2019-2030)
Figure 43. Turkey Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Tetanic Toxoid Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. BB-NCIPD Revenue Growth Rate in Tetanic Toxoid Business (2019-2024)
Figure 46. Bio Farma Revenue Growth Rate in Tetanic Toxoid Business (2019-2024)
Figure 47. Biological E Revenue Growth Rate in Tetanic Toxoid Business (2019-2024)
Figure 48. Sanofi Revenue Growth Rate in Tetanic Toxoid Business (2019-2024)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Tetanic Toxoid Business (2019-2024)
Figure 50. Accord Healthcare Inc Revenue Growth Rate in Tetanic Toxoid Business (2019-2024)
Figure 51. Shanha Biotechniques Revenue Growth Rate in Tetanic Toxoid Business (2019-2024)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock